Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

ABSTRACT: Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

PROVIDER: PRJNA597499 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

Project description:Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

| PRJNA597498 | ENA

circRNA expression in relapsed childhood acute lymphoblastic leukemia

Project description:3 patients with childhood acute lymphoblastic leukemia were diagnosed with relapsed, and the matched new diagnosed blood samples were enrolled as controls. CirRNA array were conducted for detecting the expression of miRNA in above samples.

2025-03-01 | E-MTAB-13177 | biostudies-arrayexpress

miRNA expression in relapsed childhood acute lymphoblastic leukemia

Project description:3 patients with childhood acute lymphoblastic leukemia were diagnosed with relapsed, and the matched new diagnosed blood samples were enrolled as controls. MiRNA array were conducted for detecting the expression of miRNA in above samples.

2025-03-01 | E-MTAB-13176 | biostudies-arrayexpress

Genomic Analysis of Relapsed Pediatric Acute Lymphoblastic Leukemia

Project description:<p>Although multi-agent combination chemotherapy is curative in a significant fraction of childhood acute lymphoblastic leukemia (ALL) patients, 20% of cases relapse and most die due to chemo-refractory disease. Here we used whole-exome and whole-genome sequencing to analyze the mutational landscape and pattern of clonal evolution at relapse in pediatric ALL cases. These analyses showed that ALL relapses originate from a common ancestral precursor clone of the diagnosis and relapsed populations and frequently harbor mutations implicated in chemotherapy resistance. RAS-MAPK pathway activating mutations in NRAS, KRAS and PTPN11 were present in 24/55 (44%) cases in our series. Notably, while some cases showed emergence of RAS mutant clones at relapse, in others, RAS mutant clones present at diagnosis were replaced by RAS wild type populations. Mechanistically, functional dissection of mouse and human wild type Kras and mutant Kras (Kras G12D) isogenic leukemia cells demonstrated induction of methotrexate resistance, but also improved response to vincristine, in mutant Kras- expressing lymphoblasts. These results identify chemotherapy driven selection as a central mechanism of leukemia clonal evolution and pave the road for the development of tailored personalized therapies for the treatment of relapsed ALL. </p>

| phs001072 | dbGaP

Relapsed Acute Lymphoblastic Leukemia (ALL): Genomic Analysis in Pediatric Patients

Project description:Relapsed Acute Lymphoblastic Leukemia (ALL): Genomic Analysis in Pediatric Patients

| PRJNA311978 | ENA

The Methylome Landscape of Infant B-cell precursor Acute Lymphoblastic Leukemia (iB-ALL)

Project description:B-cell acute lymphoblastic leukemia (B-ALL) is the most prevailing childhood cancer. As predicated by its prenatal origin, infant B-ALL (iB-ALL) show a silent mutational landscape irrespective of the MLL rearrangement/status, suggesting that other regulatory mechanisms might be impaired in the context of the disease. Here we used the most recent Illumina MethylationEPIC Beadchip platform to describe the genome-wide DNA methylation changes observed in a total of 69 de novo MLL-AF4+, MLL-AF9+ and non-rearranged MLL iB-ALL leukemias uniformly treated according to Interfant 99/06 protocol. Please note that samples X8 and X9 (pool of B cells and BCP) correspond to samples 200340580160_R08C01 and 200340580161_R07C01 from study E-MTAB-6315, respectively.

2021-03-12 | E-MTAB-8505 | biostudies-arrayexpress

Molecular genetics of pre-B acute lymphoblastic leukemia sister cell lines during disease progression - WES

Project description:Retaining the mutational pattern of tumors, immortalized cell lines represent excellent tools for the molecular study of genetic aberrations. Tumors can consist of subclones which develop under selective forces driven by mutational alterations. This explains why after therapy, relapsed clones can be genetically distinct from clones at diagnosis. We analyzed the mutational patterns of pairs of cell lines raised at early and late phases of development from patients with a hematopoietic tumor named pre-B acute lymphoblastic leukemia (ALL). All cell lines tested showed mutations that typically occur in this tumor. We also observed clonal differences in sister cell lines, genetic aberrations developing during disease progression. Especially noteworthy was the presence of two mutations which are hitherto undescribed in cell lines.

2021-12-02 | E-MTAB-11039 | biostudies-arrayexpress

Molecular genetics of pre-B acute lymphoblastic leukemia sister cell lines during disease progression - RNA-seq

2021-12-02 | E-MTAB-11038 | biostudies-arrayexpress

The chromatin accessibility landscape of T-Cell Acute Lymphoblastic Leukemia

Project description:We investigated the chromatin accessibility landscape of normal T cells and T-Cell Acute Lymphoblastic Leukemia to define the thymocyte development using chromatin accessibility profiles and map the aberrant leukemia-associated accessibility sites in T-ALL.

2024-12-11 | GSE160298 | GEO

Integrated Genomic Analysis of Relapsed Childhood Acute Lymphoblastic Leukemia reveals therapeutic strategies

Project description:This SuperSeries is composed of the following subset Series: GSE28460: Expression data from ALL diagnosis and relapse pediatric acute lymphoblastic leukemia cases GSE28461: Promoter methylation data from ALL diagnosis and relapse pediatric acute lymphoblastic leukemia cases Refer to individual Series

2011-09-22 | E-GEOD-28462 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data